Olainfarm produces 25 different APIs under cGMP.
Optically active APIs, which are obtained by technologies that have been developed by factory specialists in co-operation with scientists from different countries, play a special role in the product assortment. Currently, Olainfarm is actively engaged in the development of a technology for obtaining new optically active generic products. In the coming years, they could supplement the product range of JSC Olainfarm.
Olainfarm has a long-standing know-how advantage in adamantane, quinuclidine and nitrofurane chemistry, as well as optically pure ɣ– aminobutyric acid derivatives.
Interim Director of the Department of Research and Development
Phone: (+ 371) 67 013 765